- BGI Genomics Announces Pricing of Initial Public Offering
- BGI Launches the Latest Desktop Sequencer BGISEQ-50
- International Science Community Welcomes China National GeneBank Opening
- BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- The Evolution of Chronic Lymphocytic Leukemia Revealed
- BGI involved in publication of the first seahorse genome in Nature
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
- Mapping more genomes will create a healthcare 'big data revolution'
Tel: +86-755-36307212Email: firstname.lastname@example.org
On October 31, 40 officers from the Bill & Melinda Gates Foundation (BMGF) Seattle headquarters and Beijing Representative Office met with BGI executives and visited China National Gene Bank (CNGB). Gates Foundation leaders included Yinuo Li, China Director from the Beijing office; Zhen Xing, Vice Director from Beijing; and Robert Rosen, Director at the Gates Foundation in Seattle. BGI President and Co-Founder Jian Wang, along with Xun Xu, Chief Executive Officer of CNGB and Director of BGI Research; Yanmei Zhu, Executive Vice President of BGI and Director of Strategic Planning; and Yiwu He, Vice Director of BGI International Development Center, welcomed the group and presented topics including BGI's Health and Poverty Alleviation programs in China, Epidemic Disease Control in Tibet, and the Belt and Road Initiative Genomics Alliance.
Jian Wang demonstrated BGI’s ongoing programs of control of infectious diseases in Tibet. BGI is helping the autonomous region and the CDC of China to achieve full coverage for the Tibetan population in screening for infection, making a significant contribution to controlling birth defects, as well as preventing major transmission of infectious diseases.
In addition, Yiwu He also illustrated BGI's Health and Poverty Alleviation programs in China, and the Belt and Road Initiative Genomic Alliance efforts in prevention and controlling infections, birth defects, and non-communicable diseases.
BGI has partnered with with the Gates Foundation since signing a Memorandum of Understanding in 2012 on Collaboration for Global Health and Agricultural Development. Over the past five years, BGI has collaborated with the Gates Foundation and 17 world leading universities and organizations on 22 research projects in maternal neonatal health and infectious disease.